within the human body, what causes diabetic ketoacidosis to occur?

Medical condition

Diabetic ketoacidosis
Dehydration may be severe in diabetic ketoacidosis, and intravenous fluids are commonly needed equally role of its treatment.
Specialty	Endocrinology
Symptoms	Vomiting, abdominal pain, deep gasping animate, increased urination, defoliation, a specific scent[1]
Complications	Cerebral edema[2]
Usual onset	Relatively rapid[1]
Causes	Shortage of insulin[3]
Risk factors	Usually type i diabetes, less frequently other types[i]
Diagnostic method	Loftier blood sugar, low blood pH, ketoacids[1]
Differential diagnosis	Hyperosmolar nonketotic state, alcoholic ketoacidosis, uremia, salicylate toxicity[iv]
Handling	Intravenous fluids, insulin, potassium[one]
Frequency	4–25% of people with type 1 diabetes per year[1] [five]

Diabetic ketoacidosis (DKA) is a potentially life-threatening complexity of diabetes mellitus.^[1] Signs and symptoms may include airsickness, intestinal pain, deep gasping breathing, increased urination, weakness, confusion and occasionally loss of consciousness.^[ane] A person's breath may develop a specific "fruity" scent.^[one] Onset of symptoms is usually rapid.^[1] People without a previous diagnosis of diabetes may develop DKA as the first obvious symptom.^[i]

DKA happens most often in those with type i diabetes but can also occur in those with other types of diabetes under certain circumstances.^[1] Triggers may include infection, non taking insulin correctly, stroke and certain medications such equally steroids.^[i] DKA results from a shortage of insulin; in response, the body switches to called-for fat acids, which produces acidic ketone bodies.^[3] DKA is typically diagnosed when testing finds high blood sugar, low blood pH and ketoacids in either the claret or urine.^[one]

The primary treatment of DKA is with intravenous fluids and insulin.^[1] Depending on the severity, insulin may exist given intravenously or by injection under the skin.^[3] Usually, potassium is also needed to prevent the development of low blood potassium.^[1] Throughout treatment, blood sugar and potassium levels should be regularly checked.^[one] Underlying causes for the DKA should be identified.^[six] In those with severely low blood pH who are critically ill, sodium bicarbonate may exist given; withal, its use is of unclear do good and typically not recommended.^{[one] [vi]}

Rates of DKA vary around the world.^[5] In the United kingdom, about 4% of people with blazon 1 diabetes develop DKA each year, while in Malaysia the condition affects well-nigh 25% of blazon 1 diabetics a year.^{[1] [5]} DKA was first described in 1886, and until the introduction of insulin therapy in the 1920s, information technology was almost universally fatal.^[vii] The risk of death with adequate and timely treatment is between <1% and 5%.^{[1] [6]}

Signs and symptoms [edit]

The symptoms of an episode of diabetic ketoacidosis ordinarily evolve over a period of near 24 hours. Predominant symptoms are nausea and airsickness, pronounced thirst, excessive urine production and abdominal pain that may exist astringent. In severe DKA, animate becomes rapid and of a deep, gasping character, called "Kussmaul animate".^{[8] [9]} The abdomen may be tender to the betoken that a serious abdominal condition may be suspected, such as astute pancreatitis, appendicitis or gastrointestinal perforation.^[9] Airsickness altered blood that resembles coffee grounds occurs in a minority of people and tends to originate from erosion of the esophagus.^[7] In severe DKA, there may be confusion or a marked decrease in alertness, including coma.^{[6] [nine]}

On physical examination there is usually clinical evidence of aridity, such as a dry out mouth and decreased pare turgor. If the aridity is profound enough to crusade a decrease in the circulating blood book, a rapid center charge per unit and low blood pressure may exist observed. Frequently, a "ketotic" aroma is present, which is frequently described as "fruity" or similar "pear drops".^{[one] [9]} The odour is due to the presence of acetone.^[x] If Kussmaul respiration is nowadays, this is reflected in an increased respiratory charge per unit.^[9]

Minor children with DKA are relatively prone to brain swelling, also chosen cerebral edema, which may cause headache, blackout, loss of the pupillary lite reflex, and can progress to decease. It occurs in nearly 1 out of 100 children with DKA and more rarely occurs in adults.^{[iii] [ix] [11]}

Cause [edit]

DKA most frequently occurs in those who know they have diabetes, but it may also exist the kickoff presentation in someone who had non previously been known to be diabetic. In that location is often a particular underlying problem that has led to the DKA episode; this may be intercurrent illness (pneumonia, influenza, gastroenteritis, a urinary tract infection), pregnancy, inadequate insulin administration (due east.one thousand. defective insulin pen device), myocardial infarction (heart attack), stroke or the apply of cocaine. Young people with recurrent episodes of DKA may have an underlying eating disorder, or may be using bereft insulin for fear that information technology will cause weight gain.^[nine]

Diabetic ketoacidosis may occur in those previously known to take diabetes mellitus type ii or in those who on further investigations turn out to take features of type 2 diabetes (due east.thousand. obesity, strong family history); this is more common in African, African-American and Hispanic people. Their condition is then labeled "ketosis-prone type 2 diabetes".^{[3] [12]}

Drugs in the gliflozin form (SGLT2 inhibitors), which are generally used for type ii diabetes, have been associated with cases of diabetic ketoacidosis where the claret sugars may not exist significantly elevated ("euglycemic DKA").^[13] While this is a relatively uncommon agin event, information technology is idea to be more than mutual if someone receiving an SGLT2 inhibitor who is also receiving insulin has reduced or missed insulin doses. Furthermore information technology can be triggered past severe acute illness, aridity, extensive exercise, surgery, low-carbohydrate diets, or excessive alcohol intake.^[13] SGLT2 inhibitors should exist stopped before surgery and only recommenced when it is safe to practise so.^[fourteen] SGLT2 inhibitors may be used in people with type i diabetes, simply the possibility of ketoacidosis requires specific chance management. Specifically, they should not be used if someone is also using a depression sugar or ketogenic nutrition.^[fifteen]

Mechanism [edit]

Diabetic ketoacidosis arises because of a lack of insulin in the body. The lack of insulin and respective height of glucagon leads to increased release of glucose past the liver (a procedure that is commonly suppressed past insulin) from glycogen via glycogenolysis and too through gluconeogenesis. High glucose levels spill over into the urine, taking water and solutes (such as sodium and potassium) along with information technology in a process known every bit osmotic diuresis.^[iii] This leads to polyuria, dehydration, and polydipsia. The absenteeism of insulin too leads to the release of gratis fat acids from adipose tissue (lipolysis), which the liver converts into acetyl CoA through a process called beta oxidation. Acetyl CoA is metabolised into Ketone bodies nether severe states of energy deficiency, like starvation, through a process called ketogenesis, whose concluding products are aceto-acetate and β-Hydroxybutyrate. These Ketone bodies can serve equally an free energy source in the absence of insulin-mediated glucose delivery, and is a protective mechanism in case of starvation. The ketone bodies, all the same, have a depression pKa and therefore plough the blood acidic (metabolic acidosis). The body initially buffers the change with the bicarbonate buffering system, but this system is speedily overwhelmed and other mechanisms must piece of work to compensate for the acidosis.^[iii] 1 such mechanism is hyperventilation to lower the blood carbon dioxide levels (a form of compensatory respiratory alkalosis). This hyperventilation, in its extreme form, may exist observed as Kussmaul respiration.^[9]

In various situations such every bit infection, insulin demands rise but are not matched by the failing pancreas. Blood sugars rise, dehydration ensues, and resistance to the normal furnishings of insulin increases further by manner of a fell circle.^{[3] [7]}

As a result of the above mechanisms, the average adult with DKA has a total torso water shortage of about 6 liters (or 100 mL/kg), in improver to substantial shortages in sodium, potassium, chloride, phosphate, magnesium and calcium. Glucose levels usually exceed 13.8 mmol/50 or 250 mg/dL.^[16]

β-hydroxybutyrate (the cohabit base of β-hydroxybutyric acid, drawn above) despite chemically containing a carboxylate group instead of a ketone, is the master "ketone torso" in diabetic ketoacidosis.

DKA is common in type 1 diabetes as this course of diabetes is associated with an absolute lack of insulin production by the islets of Langerhans. In type ii diabetes, insulin production is present simply is insufficient to encounter the torso's requirements every bit a result of terminate-organ insulin resistance. Commonly, these amounts of insulin are sufficient to suppress ketogenesis. If DKA occurs in someone with type 2 diabetes, their condition is called "ketosis-decumbent blazon ii diabetes".^[12] The exact mechanism for this phenomenon is unclear, merely at that place is evidence both of dumb insulin secretion and insulin activeness.^{[3] [12]} In one case the condition has been treated, insulin production resumes and often the person may be able to resume diet or tablet handling as usually recommended in type two diabetes.^[iii]

The clinical state of DKA is associated, in improver to the above, with the release of various counterregulatory hormones such as glucagon and adrenaline equally well as cytokines, the latter of which leads to increased markers of inflammation, even in the absence of infection.^{[three] [17]}

Cerebral edema, which is the well-nigh dangerous DKA complication, is probably the event of a number of factors. Some authorities suggest that it is the result from overvigorous fluid replacement, but the complication may develop earlier treatment has been commenced.^{[11] [18]} Information technology is more probable in those with more severe DKA,^[17] and in the outset episode of DKA.^[xi] Likely factors in the development of cerebral edema are dehydration, acidosis and low carbon dioxide levels; in addition, the increased level of inflammation and coagulation may, together with these factors, lead to decreased blood menses to parts of the brain, which so swells up once fluid replacement has been commenced.^[xi] The swelling of encephalon tissue leads to raised intracranial pressure level ultimately leading to death.^{[17] [18]}

Diagnosis [edit]

Investigations [edit]

Diabetic ketoacidosis may be diagnosed when the combination of hyperglycemia (high claret sugars), ketones in the claret or on urinalysis and acidosis are demonstrated.^[half-dozen] In about 10% of cases the claret sugar is non significantly elevated ("euglycemic diabetic ketoacidosis").^[three]

A pH measurement is performed to observe acidosis. Claret from a vein is adequate, as at that place is little departure between the arterial and the venous pH; arterial samples are only required if at that place are concerns nearly oxygen levels.^[6] Ketones can be measured in the urine (acetoacetate) and claret (β-hydroxybutyrate). When compared with urine acetoacetate testing, capillary claret β-hydroxybutyrate determination tin can reduce the need for access, shorten the duration of hospital admission and potentially reduce the costs of hospital care.^[19] At very high levels, capillary blood ketone measurement becomes imprecise.^[20]

In addition to the above, claret samples are normally taken to measure urea and creatinine (measures of kidney function, which may exist impaired in DKA equally a outcome of dehydration) and electrolytes. Furthermore, markers of infection (complete claret count, C-reactive protein) and acute pancreatitis (amylase and lipase) may be measured. Given the need to exclude infection, chest radiography and urinalysis are ordinarily performed.^[3]

If cerebral edema is suspected because of confusion, recurrent vomiting or other symptoms, computed tomography may exist performed to assess its severity and to exclude other causes such as stroke.^[18]

Criteria [edit]

Diabetic ketoacidosis is distinguished from other diabetic emergencies by the presence of big amounts of ketones in blood and urine, and marked metabolic acidosis. Hyperosmolar hyperglycemic country (HHS, sometimes labeled "hyperosmolar non-ketotic state" or HONK) is much more than common in blazon 2 diabetes and features increased plasma osmolarity (above 320 mosm/kg) due to profound dehydration and concentration of the blood; balmy acidosis and ketonemia may occur in this state, just not to the extent observed in DKA. There is a caste of overlap between DKA and HHS, as in DKA the osmolarity may also be increased.^[three]

Ketoacidosis is non ever the result of diabetes. It may also upshot from alcohol backlog and from starvation; in both states the glucose level is normal or low. Metabolic acidosis may occur in people with diabetes for other reasons, such as poisoning with ethylene glycol or paraldehyde.^[3]

The American Diabetes Association categorizes DKA in adults into i of 3 stages of severity:^[iii]

• Mild: blood pH mildly decreased to between 7.25 and vii.30 (normal 7.35–7.45); serum bicarbonate decreased to 15–18 mmol/l (normal above twenty); the person is alarm
• Moderate: pH 7.00–7.25, bicarbonate ten–15, mild drowsiness may exist present
• Severe: pH beneath 7.00, bicarbonate below x, daze or coma may occur

A 2004 statement by the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society (for children) uses slightly different cutoffs, where mild DKA is defined by pH 7.20–7.30 (bicarbonate 10–fifteen mmol/l), moderate DKA by pH 7.i–7.2 (bicarbonate 5–x) and severe DKA by pH<7.ane (bicarbonate below 5).^[17]

Prevention [edit]

Attacks of DKA tin can be prevented in those known to have diabetes to an extent by adherence to "sick mean solar day rules";^[6] these are clear-cut instructions to person on how to treat themselves when unwell. Instructions include advice on how much extra insulin to accept when sugar levels appear uncontrolled, an hands digestible nutrition rich in table salt and carbohydrates, means to suppress fever and treat infection, and recommendations when to call for medical help.^[three]

People with diabetes can monitor their own ketone levels when unwell and seek help if they are elevated.^[21]

Management [edit]

The chief aims in the treatment of diabetic ketoacidosis are replacing the lost fluids and electrolytes while suppressing the loftier blood sugars and ketone production with insulin. Access to an intensive care unit (ICU) or like high-dependency area or ward for close ascertainment may be necessary.^[half-dozen]

Fluid replacement [edit]

The amount of fluid replaced depends on the estimated degree of dehydration. If dehydration is then severe every bit to cause shock (severely decreased blood pressure level with insufficient blood supply to the body's organs), or a depressed level of consciousness, rapid infusion of saline (one liter for adults, ten ml/kg in repeated doses for children) is recommended to restore circulating volume.^{[3] [22]} Slower rehydration based on calculated h2o and sodium shortage may be possible if the aridity is moderate, and over again saline is the recommended fluid.^{[21] [22]} Very mild ketoacidosis with no associated airsickness and mild aridity may be treated with oral rehydration and subcutaneous rather than intravenous insulin under observation for signs of deterioration.^[22]

Normal saline (0.nine% saline) has generally been the fluid of pick.^[23] At that place have been a few pocket-size trials looking at counterbalanced fluids with few differences.^[23]

A special but unusual consideration is cardiogenic daze, where the claret force per unit area is decreased non due to dehydration merely due to disability of the heart to pump blood through the claret vessels. This situation requires ICU access, monitoring of the central venous pressure (which requires the insertion of a key venous catheter in a large upper body vein), and the assistants of medication that increases the heart pumping activeness and blood pressure.^[3]

Insulin [edit]

Some guidelines recommend a bolus (initial large dose) of insulin of 0.ane unit of insulin per kilogram of body weight. This can be administered immediately afterwards the potassium level is known to be college than 3.3 mmol/l; if the level is any lower, administering insulin could pb to a dangerously low potassium level (run into beneath).^[3] Other guidelines recommend a bolus given intramuscularly if there is a delay in commencing an intravenous infusion of insulin,^[6] whereas guidelines for the direction of pediatric DKA recommend delaying the initiation of insulin until fluids have been administered.^[22] It is possible to use rapid acting insulin analogs injections under the skin for mild or moderate cases.^[24]

In general, insulin is given at 0.1 unit of measurement/kg per hr to reduce the blood sugars and suppress ketone production. Guidelines differ every bit to which dose to use when blood sugar levels outset falling; American guidelines recommend reducing the dose of insulin once glucose falls below 16.6 mmol/l (300 mg/dl)^[3] and UK guidelines at 14 mmol/l (253 mg/dl).^[6] Others recommend infusing glucose in improver to saline to let for ongoing infusion of college doses of insulin.^{[21] [22]}

Potassium [edit]

Potassium levels tin can fluctuate severely during the handling of DKA, because insulin decreases potassium levels in the blood past redistributing it into cells via increased sodium-potassium pump activity. A large part of the shifted extracellular potassium would have been lost in urine because of osmotic diuresis. Hypokalemia (low blood potassium concentration) oft follows treatment. This increases the risk of dangerous irregularities in the heart rate. Therefore, continuous observation of the centre rate is recommended,^{[6] [22]} as well as repeated measurement of the potassium levels and addition of potassium to the intravenous fluids once levels fall below 5.3 mmol/l. If potassium levels fall beneath iii.3 mmol/50, insulin administration may demand to be interrupted to let correction of the hypokalemia.^[3]

Sodium bicarbonate [edit]

The administration of sodium bicarbonate solution to quickly meliorate the acid levels in the blood is controversial. At that place is piddling bear witness that it improves outcomes beyond standard therapy, and indeed some show that while it may improve the acidity of the blood, it may actually worsen acidity inside the torso's cells and increment the hazard of certain complications. Its employ is therefore discouraged,^{[6] [17] [21]} although some guidelines recommend it for extreme acidosis (pH<6.9), and smaller amounts for severe acidosis (pH six.9–7.0).^[3]

Cerebral edema [edit]

Cerebral edema, if associated with coma, often necessitates access to intensive care, artificial ventilation, and close observation. The assistants of fluids is slowed. The ideal handling of cerebral edema in DKA is not established, but intravenous mannitol and hypertonic saline (3%) are used—as in some other forms of cognitive edema—in an attempt to reduce the swelling.^[17] Cerebral edema is unusual in adults.^[6]

Resolution [edit]

Resolution of DKA is defined equally general improvement in the symptoms, such as the ability to tolerate oral nutrition and fluids, normalization of blood acidity (pH>vii.3), and absenteeism of ketones in blood (<1 mmol/fifty) or urine. One time this has been achieved, insulin may exist switched to the usual subcutaneously administered regimen, one hour after which the intravenous administration can be discontinued.^{[vi] [22]}

In people with suspected ketosis-prone blazon ii diabetes, conclusion of antibodies confronting glutamic acid decarboxylase and islet cells may aid in the decision whether to go along insulin assistants long-term (if antibodies are detected), or whether to withdraw insulin and endeavor treatment with oral medication as in type 2 diabetes.^[12] Generally speaking, routine measurement of C-peptide as a measure of insulin production is not recommended unless in that location is genuine incertitude as to whether someone has type 1 or type two diabetes.^[21]

Epidemiology [edit]

Diabetic ketoacidosis occurs in 4.vi–8.0 per thousand people with diabetes annually.^[16] Rates among those with type 1 diabetes are higher with about 4% in United Kingdom developing DKA a twelvemonth while in Malaysia the condition affects about 25% a twelvemonth.^{[1] [v]} In the United States, 135,000 hospital admissions occur annually every bit a effect of DKA, at an estimated price of $2.4 billion or a quarter to a half the total cost of caring for people with type 1 diabetes. There has been a documented increasing trend to hospital admissions.^[3] The hazard is increased in those with an ongoing gamble gene, such equally an eating disorder, and those who cannot afford insulin.^[3] About 30% of children with type 1 diabetes receive their diagnosis after an episode of DKA.^[25] Lower socio‐economic status and higher area‐level impecuniousness are associated with an increased adventure of diabetic ketoacidosis in people with diabetes mellitus type 1.^[26]

Previously considered universally fatal, the gamble of expiry with acceptable and timely treatment is between <one% and 5%^{[1] [half dozen]} Up to one% of children with DKA develop a complication known as cerebral edema.^[2] Rates of cerebral edema in United states children with DKA has risen from 0.4% in 2002 to 0.7% in 2012.^[27] Between 2 and five out of x children who develop encephalon swelling will die every bit a result.^[eighteen]

History [edit]

The first full description of diabetic ketoacidosis is attributed to Julius Dreschfeld, a German pathologist working in Manchester, United Kingdom. In his description, which he gave in an 1886 lecture at the Royal Higher of Physicians in London, he drew on reports by Adolph Kussmaul as well as describing the main ketones, acetoacetate and β-hydroxybutyrate, and their chemical determination.^[28] The condition remained almost universally fatal until the discovery of insulin in the 1920s; by the 1930s, mortality had fallen to 29 pct,^[seven] and by the 1950s it had become less than 10 percent.^[29] The entity of cerebral edema due to DKA was described in 1936 by a team of doctors from Philadelphia.^{[xviii] [30]}

Numerous research studies since the 1950s have focused on the platonic treatment for diabetic ketoacidosis. A pregnant proportion of these studies have been conducted at the University of Tennessee Health Scientific discipline Heart and Emory University Schoolhouse of Medicine.^[29] Treatment options studied have included high- or low-dose intravenous, subcutaneous or intramuscular (e.thou. the "Alberti government") insulin, phosphate supplementation, need for a loading dose of insulin, and appropriateness of using bicarbonate therapy in moderate DKA.^[29] Diverse questions remain unanswered, such as whether bicarbonate administration in severe DKA makes whatsoever real deviation to the clinical course, and whether an insulin loading dose is needed in adults.^[29]

The entity of ketosis-prone blazon 2 diabetes was first fully described in 1987 afterward several preceding case reports. It was initially thought to be a form of maturity onset diabetes of the young,^[31] and went through several other descriptive names (such as "idiopathic type 1 diabetes", "Flatbush diabetes", "atypical diabetes" and "blazon i.five diabetes") earlier the current terminology of "ketosis-decumbent type two diabetes" was adopted.^{[three] [12]}

References [edit]

1. ^ ^{a b c d e f thousand h i j yard 50 m n o p q r s t u five westward} Misra, S; Oliver, NS (28 October 2015). "Diabetic ketoacidosis in adults" (PDF). BMJ (Clinical Research Ed.). 351: h5660. doi:10.1136/bmj.h5660. hdl:10044/1/41091. PMID 26510442. S2CID 38872958.
2. ^ ^{a b} Bialo, SR; Agrawal, South; Boney, CM; Quintos, JB (15 February 2015). "Rare complications of pediatric diabetic ketoacidosis". World Journal of Diabetes. six (1): 167–74. doi:10.4239/wjd.v6.i1.167. PMC4317308. PMID 25685287.
3. ^ ^{a b c d e f k h i j k l grand n o p q r south t u v w ten y z} Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN (July 2009). "Hyperglycemic crises in adult patients with diabetes". Diabetes Care. 32 (vii): 1335–43. doi:10.2337/dc09-9032. PMC2699725. PMID 19564476.
4. ^ Ferri, Fred F. (2010). Ferri's Differential Diagnosis: A Practical Guide to the Differential Diagnosis of Symptoms, Signs, and Clinical Disorders. Elsevier Health Sciences. p. 146. ISBN978-0323076999. Archived from the original on 2017-09-08.
5. ^ ^{a b c d} Maletkovic, J; Drexler, A (December 2013). "Diabetic ketoacidosis and hyperglycemic hyperosmolar state". Endocrinology and Metabolism Clinics of Northward America. 42 (4): 677–95. doi:10.1016/j.ecl.2013.07.001. PMID 24286946.
6. ^ ^{a b c d e f g h i j k 50 m north o} Articulation British Diabetes Societies Inpatient Care Group (June 2021). "The Management of Diabetic Ketoacidosis in Adults". Association of British Clinical Diabetologists. Retrieved 10 August 2021.
7. ^ ^{a b c d} Eledrisi MS, Alshanti MS, Shah MF, Brolosy B, Jaha Due north (May 2006). "Overview of the diagnosis and direction of diabetic ketoacidosis". American Journal of the Medical Sciences. 331 (v): 243–51. doi:10.1097/00000441-200605000-00002. PMID 16702793.
8. ^ Kliegman, [edited by] Karen J. Marcdante, Robert M. (2015). Nelson essentials of pediatrics (7th ed.). pp. 573–576. ISBN9781455759804.
9. ^ ^{a b c d e f thou h} Powers Air-conditioning (2005). Kasper DL, Braunwald East, Fauci AS, et al. (eds.). Harrison'due south Principles of Internal Medicine (16th ed.). New York, NY: McGraw-Hill. pp. 2152–2180. ISBN978-0-07-139140-v.
10. ^ Elzouki, A. Y.; Harfi, H. A.; Nazer, H.; Oh, William; Stapleton, F. B.; Whitley, R. J. (2011). Textbook of Clinical Pediatrics. Springer Science & Concern Media. p. 2567. ISBN9783642022012.
11. ^ ^{a b c d} Glaser N (June 2006). "New perspectives on the pathogenesis of cerebral edema complicating diabetic ketoacidosis in children". Pediatric Endocrinology Reviews. 3 (iv): 379–86. PMID 16816806.
12. ^ ^{a b c d e} Umpierrez GE, Smiley D, Kitabchi AE (March 2006). "Narrative review: ketosis-prone type 2 diabetes mellitus". Annals of Internal Medicine. 144 (5): 350–7. doi:10.7326/0003-4819-144-5-200603070-00011. PMID 16520476. S2CID 33296818.
13. ^ ^{a b} Goldenberg, RM; Berard, LD; Cheng, AYY; Gilbert, JD; Verma, S; Woo, VC; Yale, JF (December 2016). "SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis". Clinical Therapeutics. 38 (12): 2654–2664.e1. doi:10.1016/j.clinthera.2016.11.002. PMID 28003053.
14. ^ Milder, D. A.; Milder, T. Y.; Kam, P. C. A. (August 2018). "Sodium-glucose co-transporter type-2 inhibitors: pharmacology and peri-operative considerations". Anaesthesia. 73 (viii): 1008–1018. doi:ten.1111/anae.14251. PMID 29529345.
15. ^ Danne, Thomas; Garg, Satish; Peters, Anne 50.; Buse, John B.; Mathieu, Chantal; Pettus, Jeremy H.; Alexander, Charles One thousand.; Battelino, Tadej; Ampudia-Blasco, F. Javier; Bode, Bruce W.; Cariou, Bertrand; Close, Kelly 50.; Dandona, Paresh; Dutta, Sanjoy; Ferrannini, Ele; Fourlanos, Spiros; Grunberger, George; Heller, Simon R.; Henry, Robert R.; Kurian, Martin J.; Kushner, Jake A.; Oron, Tal; Parkin, Christopher G.; Pieber, Thomas R.; Rodbard, Helena W.; Schatz, Desmond; Skyler, Jay S.; Tamborlane, William V.; Yokote, Koutaro; Phillip, Moshe (6 February 2019). "International Consensus on Risk Direction of Diabetic Ketoacidosis in Patients with Type 1 Diabetes Treated with Sodium-Glucose Cotransporter (SGLT) Inhibitors". Diabetes Care. 42 (half-dozen): 1147–1154. doi:ten.2337/dc18-2316. PMC6973545. PMID 30728224. Equally a full general guideline, SGLT-inhibitor therapy should not exist used in patients using lowcarbohydrate or ketogenic diets as, anecdotally, they seem to be at increased risk of adverse ketosis effects
16. ^ ^{a b} Kitabchi AE, Umpierrez GE, Murphy MB, Kreisberg RA (Dec 2006). "Hyperglycemic crises in adult patients with diabetes: a consensus argument from the American Diabetes Association". Diabetes Care. 29 (12): 2739–48. doi:10.2337/dc06-9916. PMID 17130218. Archived from the original on 2010-03-27.
17. ^ ^{a b c d e f} Dunger DB, Sperling MA, Acerini CL, et al. (February 2004). "European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society consensus statement on diabetic ketoacidosis in children and adolescents". Pediatrics. 113 (2): e133–twoscore. doi:10.1542/peds.113.two.e133. PMID 14754983. Archived from the original on 2009-09-12.
18. ^ ^{a b c d due east} Brown TB (March 2004). "Cerebral oedema in childhood diabetic ketoacidosis: Is treatment a factor?". Emergency Medicine Journal. 21 (2): 141–iv. doi:10.1136/emj.2002.001578. PMC1726262. PMID 14988335.
19. ^ Klocker AA, Phelan H, Twigg SM, Craig ME (July 2013). "Blood β-hydroxybutyrate vs. urine acetoacetate testing for the prevention and management of ketoacidosis in Type 1 diabetes: a systematic review". Diabet. Med. 30 (7): 818–24. doi:10.1111/dme.12136. PMID 23330615. S2CID 22070325.
20. ^ Misra, Due south; Oliver, NS (January 2015). "Utility of ketone measurement in the prevention, diagnosis and management of diabetic ketoacidosis". Diabetic Medicine. 32 (one): 14–23. doi:10.1111/dme.12604. PMID 25307274. S2CID 11923923.
21. ^ ^{a b c d e} "Type 1 diabetes in adults: diagnosis and management". National Institute for Health and Care Excellence. August 2015. Archived from the original on 9 Baronial 2016. Retrieved 10 February 2016.
22. ^ ^{a b c d e f thou} Edge J (May 2009). "BSPED Recommended DKA Guidelines 2009" (PDF). British Society for Paediatric Endocrinology and Diabetes. Archived from the original (PDF) on 2011-10-27. Retrieved 2009-07-12 .
23. ^ ^{a b} Jayashree, Muralidharan; Williams, Vijai; Iyer, Rajalakshmi (2019). "Fluid Therapy For Pediatric Patients With Diabetic Ketoacidosis: Current Perspectives". Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 12: 2355–2361. doi:ten.2147/DMSO.S194944. ISSN 1178-7007. PMC6858801. PMID 31814748.
24. ^ Andrade-Castellanos, CA; Colunga-Lozano, LE; Delgado-Figueroa, North; Gonzalez-Padilla, DA (21 January 2016). "Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis". The Cochrane Database of Systematic Reviews. 1 (i): CD011281. doi:10.1002/14651858.CD011281.pub2. PMID 26798030.
25. ^ Silverstein J, Klingensmith Thousand, Copeland K, et al. (January 2005). "Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association". Diabetes Care. 28 (ane): 186–212. doi:x.2337/diacare.28.1.186. PMID 15616254. Archived from the original on 2016-04-19.
26. ^ Lindner, L. M. E.; Rathmann, W.; Rosenbauer, J. (January 2018). "Inequalities in glycaemic control, hypoglycaemia and diabetic ketoacidosis according to socio-economic status and surface area-level deprivation in Type ane diabetes mellitus: a systematic review". Diabetic Medicine. 35 (i): 12–32. doi:10.1111/dme.13519. PMID 28945942. S2CID 24297858.
27. ^ Patel, A; Singh, D; Bhatt, P; Thakkar, B; Akingbola, OA; Srivastav, SK (24 November 2015). "Incidence, Trends, and Outcomes of Cerebral Edema Amid Children With Diabetic Ketoacidosis in the United states". Clinical Pediatrics. 55 (x): 943–951. doi:x.1177/0009922815617975. PMID 26603587. S2CID 25624176.
28. ^ Dreschfeld J (1886). "The Bradshawe Lecture on Diabetic Coma". British Medical Journal. ii (1338): 358–63. doi:10.1136/bmj.2.1338.358. PMC2256374. PMID 20751675.
29. ^ ^{a b c d} Kitabchi AE, Umpierrez GE, Fisher JN, Murphy MB, Stentz FB (May 2008). "Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar land". Journal of Clinical Endocrinology and Metabolism. 93 (5): 1541–52. doi:10.1210/jc.2007-2577. PMC2386681. PMID 18270259.
30. ^ Dillon ES, Riggs HE, Dyer WW (1936). "Cerebral lesions in uncomplicated fatal diabetic acidosis". American Periodical of the Medical Sciences. 192 (3): 360–365. doi:x.1097/00000441-193609000-00007. S2CID 72917358.
31. ^ Winter We, Maclaren NK, Riley WJ, Clarke DW, Kappy MS, Spillar RP (February 1987). "Maturity-onset diabetes of youth in black Americans". New England Journal of Medicine. 316 (6): 285–91. doi:ten.1056/NEJM198702053160601. PMID 3543673.

External links [edit]

ledesmahintud.blogspot.com

Source: https://en.wikipedia.org/wiki/Diabetic_ketoacidosis

Share this post